Fujirebio Europe (previously Innogenetics), a leading international healthcare company that conceives, develops, produces and markets high quality in vitro diagnostics (IVD) testing solutions worldwide, will be presenting its LUMIPULSE® G1200, a fully automated chemiluminescent enzyme immunoassay (CLEIA) system, at the 10th Deutsche Vereinte Gesellschaft für Klinische Chemie und Laboratoriumsmedizin (DGKL) Congress in the Internationales Congress Center Dresden, Germany, from October 23rd to 26th. The LUMIPULSE® G1200 will be presented at the Fujirebio Europe booth #23 during all 4 days of the congress.